• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$12.20 -$0.13 (-1.05%)

REAL-TIME: Last trade at

AngioDynamics, Inc.

NASDAQ:ANGO

The Zacks Analyst Blog Highlights: AngioDynamics, J.P. Morgan, Bank of America, KeyCorp and CR Bard

Angio Completes Key Acquisition - Analyst Blog

CR Bard Beats EPS Est., Lags Rev - Analyst Blog

AngioDynamics Ships NanoKnife Again - Analyst Blog

1 Reason to Expect Big Things from AngioDynamics

AngioDynamics Goes Red

ANGO Mixed, Adjusts View - Analyst Blog

24/7 Wall St. Closing Bell (GOOG, CMA, AIG, DE, PNRA, ANGO, HWD, PSMT, STZ, LEDS, WDFC, PLCM, ALTH,

S&P 500 Tests Support at its 14-Day Moving Average

24/7 Wall St. Closing Bell (IBM, MCD, LUV, SNDK, BX, TISI, MIND, MON, AYI, ANGO, PSMT, STZ, PIR, LED

5 Reasons to Worry About Next Week

How Does Boston Scientific Boost its Returns?

AngioDynamics' NeverTouch Kit OK'd - Analyst Blog

3 Stocks Near 52-Week Lows Worth Buying

Earnings Scorecard: C.R. Bard - Analyst Blog

AngioDynamics to Buy Navilyst - Analyst Blog

Bard Tops in 4Q, Charges Crimp Net - Analyst Blog

Earnings Preview: C.R. Bard - Analyst Blog

AngioDynamics Cuts View on Recall - Analyst Blog

Does Boston Scientific Pass Buffett's Test?

Tuebingen UMS Deploys BSD's System - Analyst Blog

Bearish MACD for AngioDynamics - Tale of the Tape

1 Reason the Street Should Expect Big Things From AngioDynamics

Success for BSD's Rental Program - Analyst Blog

Retaining AngioDynamics at Neutral - Analyst Blog

AngioDynamics Beats Estimates on Top and Bottom Lines

AngioDynamics Beats, Tweaks View - Analyst Blog

US Stock Futures: HOT STOCKS TO WATCH

Milestone for BSD's MicroThermX - Analyst Blog

US Stock Futures: HOT STOCKS TO WATCH

CR Bard Passes This Key Test

BSD, AngioCare in MicroThermX Pact - Analyst Blog

AngioDynamics Concludes Enrollment - Analyst Blog

BSD Medical's MicroThermX at RSNA - Analyst Blog

C.R. Bard Reaffirmed Neutral - Analyst Blog

BSD, Synapse in MicroThermX Tie-up - Analyst Blog

A Not-So-Dynamic Quarter for AngioDynamics

A Hidden Reason Why the Future Looks Bright for Vascular Solutions

1 Reason Boston Scientific's Earnings Aren't So Hot

Buy This Cancer-Killer

See More Articles...